Clostridium difficile

References

1. Brun P., Scarpa M., Grillo A., Palù G., Mengoli C., Zecconi A., Spigaglia P., Mastrantonio P., Castagliuolo I. 2008; Clostridium difficile TxA_C314 and SLP-36kDa enhance the immune response toward a co-administered antigen. J Med Microbiol 57:725–731 [CrossRef]
   [Google Scholar]
2. Dawson L. F., Stabler R. A., Wren B. W. 2008; Assessing the role of p -cresol tolerance in Clostridium difficile . J Med Microbiol 57:745–749 [CrossRef]
   [Google Scholar]
3. Denève C., Deloménie C., Barc M.-C., Collignon A., Janoir C. 2008; Antibiotics involved in Clostridium difficile -associated disease increase colonization factor gene expression. J Med Microbiol 57:732–738 [CrossRef]
   [Google Scholar]
4. Dupuy B., Govind R., Antunes A., Matamouros S. 2008; Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 57:685–689 [CrossRef]
   [Google Scholar]
5. Emerson J. E., Stabler R. A., Wren B. W., Fairweather N. F. 2008; Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol 57:757–764 [CrossRef]
   [Google Scholar]
6. Gerber M., Walch C., Löffler B., Tischendorf K., Reischl U., Ackermann G. 2008; Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile . J Med Microbiol 57:776–783 [CrossRef]
   [Google Scholar]
7. Gerhard R., Nottrott S., Schoentaube J., Tatge H., Olling A., Just I. 2008; Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 57:765–770 [CrossRef]
   [Google Scholar]
8. Giesemann T., Egerer M., Jank T., Aktories K. 2008; Processing of Clostridium difficile toxins. J Med Microbiol 57:690–696 [CrossRef]
   [Google Scholar]
9. Indra A., Schmid D., Huhulescu S., Hell M., Gattringer R., Hasenberger P., Fiedler A., Wewalka G., Allerberger F. 2008; Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006–2007. J Med Microbiol 57:702–708 [CrossRef]
   [Google Scholar]
10. Pirs T., Ocepek M., Rupnik M. 2008; Isolation of Clostridium difficile from food animals in Slovenia. J Med Microbiol 57:790–792 [CrossRef]
    [Google Scholar]
11. Sánchez-Hurtado K., Poxton I. R. 2008; Enhancement of the cytotoxic activity of Clostridium difficile toxin A by surface-associated antigens. J Med Microbiol 57:739–744 [CrossRef]
    [Google Scholar]
12. Sánchez-Hurtado K., Corretge M., Mutlu E., McIlhagger R., Starr J. M., Poxton I. R. 2008; Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls. J Med Microbiol 57:717–724 [CrossRef]
    [Google Scholar]
13. Shin B.-M., Kuak E. Y., Yoo H. M., Kim E. C., Lee K., Kang J.-O., Whang D. H., Shin J.-H. 2008; Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000–2005. J Med Microbiol 57:697–701 [CrossRef]
    [Google Scholar]
14. Sleator R. D., Hill C. 2008; Designer probiotics: a potential therapeutic for Clostridium difficile . J Med Microbiol 57:793–794 [CrossRef]
    [Google Scholar]
15. Spigaglia P., Barbanti F., Mastrantonio P., Brazier J. S., Barbut F., Delmée M., Kuijper E., Poxton I. R. on behalf of the European Study Group on Clostridium difficile (ESGCD) 2008; Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol 57:784–789 [CrossRef]
    [Google Scholar]
16. Stabler R. A., Dawson L. F., Phua L. T. H., Wren B. W. 2008; Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene ( tcdB ) sequences. J Med Microbiol 57:771–775 [CrossRef]
    [Google Scholar]
17. Van der Kooi T. I. I., Koningstein M., Lindemans A., Notermans D. W., Kuijper E., Van den Berg R., Boshuizen H., Filius P. M. G., Van den Hof S. 2008; Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol 57:709–716 [CrossRef]
    [Google Scholar]
18. Wright A., Drudy D., Kyne L., Brown K., Fairweather N. F. 2008; Immunoreactive cell wall proteins of Clostridium difficile identified by human sera. J Med Microbiol 57:750–756 [CrossRef]
    [Google Scholar]